Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability (Q42596615)
Jump to navigation
Jump to search
scientific article published on September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability |
scientific article published on September 2006 |
Statements
1 reference
Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability (English)
1 reference
Stacey L Silvers
1 reference
Joseph A Eviatar
1 reference
Michael I Echavez
1 reference
Alexandra L Pappas
1 reference
1 September 2006
1 reference
1 reference
118
1 reference
3 Suppl
1 reference
34S-45S
1 reference
Identifiers
1 reference
1 reference